Prosecution Insights
Last updated: April 19, 2026
Application No. 18/983,707

POLYMER MATERIAL

Non-Final OA §103§112
Filed
Dec 17, 2024
Examiner
STRAH, ELI D
Art Unit
1782
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Menicon Co. Ltd.
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
3y 7m
To Grant
94%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allow Rate
241 granted / 479 resolved
-14.7% vs TC avg
Strong +44% interview lift
Without
With
+43.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
25 currently pending
Career history
504
Total Applications
across all art units

Statute-Specific Performance

§103
52.7%
+12.7% vs TC avg
§102
8.2%
-31.8% vs TC avg
§112
24.1%
-15.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 479 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-19 are pending in the current application. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 11 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 11 recites the phrase “the monomer components (a) further comprise a functional monomer (a-5), where the functional monomer (a-5) includes a polymerizable dyestuff, a polymerizable ultraviolet absorber, and a polymerizable ultraviolet absorbing dyestuff.” It is unclear if the claim requires at least one functional monomer (a-5) component (namely, at least one functional monomer (a-5) selected from the group consisting of a polymerizable dyestuff, a polymerizable ultraviolet absorber, and a polymerizable ultraviolet absorbing dyestuff), or if the claim requires three specific functional (a-5) monomers (namely, the monomer components (a) further comprise a polymerizable dyestuff functional monomer (a-5), a polymerizable ultraviolet absorber functional monomer (a-5), and a polymerizable ultraviolet absorbing dyestuff functional monomer (a-5)). For the purposes of examination, claim 11 is interpreted as requiring at least one functional monomer (a-5) component, and is interpreted as instead reciting “the monomer components (a) further comprise a functional monomer (a-5), where the functional monomer (a-5) includes at least one selected from the group consisting of a polymerizable dyestuff, a polymerizable ultraviolet absorber, and a polymerizable ultraviolet absorbing dyestuff. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-16, 18, and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Vanderlaan et al. (US 2010/0280146 A1) in view of Ito et al. (US 2004/0054106 A1). Regarding Claims 1 and 4, Vanderlaan teaches a polymer composition (material) for ophthalmic contact lenses comprising a silicone containing component, a hydrophilic component (a polymerizable mixture containing monomer components (a) that include (a-1) of claim 1 and (a-3) of claim 4), a high molecular weight hydrophilic polymer (a hydrophilic polymer component (b)), and a compatibilizing agent (Vanderlaan, [0002], [0006]-[0016]). Vanderlaan teaches the silicone containing component (a-1) is a monomer that contains a siloxane bond and is free of hydroxyl groups (Vanderlaan, [0031]-[0033], [0044]-[0060]). Vanderlaan teaches the hydrophilic component (a-3) includes hydrophilic monomers as required by claim 4 (Vanderlaan, [0062]-[0067]). Vanderlaan teaches the polymer composition (material) for ophthalmic contact lenses has a water content of greater than about 17%, and preferably greater than about 25% by weight (Vanderlaan, [0062], [0083]). Vanderlaan’s water content falls within the claimed range of 11 mass% or more, and therefore, satisfies the claimed range (MPEP 2131.03). Vanderlaan remains silent regarding a compatibilizing monomer (a-2) having a hydrogen bonding proton-containing group (such as a hydroxyl group) and being free of any silicon atoms, where the compatibilizing monomer (a-2) has four or more carbon atoms (excluding carbon atoms contained in a polymerizable functional group) and has a solubility of less than 0.03 g/mL in water at 25oC. Ito, however, teaches a polymer composition (material) for ophthalmic contact lenses comprising a silicone containing monomer, a hydrophilic monomer, and a fluorine-containing monomer (Ito, [0001], [0009]-[0057], [0063]-[0071]). Ito discloses the fluorine-containing monomer is preferably a fluoroalkyl acrylate as depicted below having an R’1 as a perfluoroalkyl preferably of 4-6 carbon atoms to impart flexibility, wettability, sufficient oxygen permeability, and lipid-stain resistance (Ito, [0068]-[0069]). Ito’s fluoroalkyl acrylate having a perfluoroalkyl group of 4 carbon atoms is identical to the compatibilizing monomer (a-2) example in the specification as originally filed on page 60 having solubility of less than 0.01 g/mL in water at 25oC (Spec, Pg 60). "Products of identical chemical composition can not have mutually exclusive properties." In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. Id. In view of the foregoing, Ito’s fluoroalkyl acrylate having a perfluoroalkyl group of 4 carbon atoms is considered to inherently exhibit a solubility of less than 0.01 g/mL in water at 25oC and exhibit compatibilizing properties. It would have been obvious to one of ordinary skill in the art to have selected and to have tried Ito’s fluoroalkyl acrylate having a perfluoroalkyl group of 4 carbon atoms from the finite list of viable fluorine-containing monomers, and moreover, to impart flexibility, wettability, sufficient oxygen permeability, and lipid-stain resistance with a predictable and reasonable expectation of success (Ito, [0068]-[0069]; MPEP 2143). PNG media_image1.png 80 248 media_image1.png Greyscale Ito – Fluoroalkyl acrylate PNG media_image2.png 141 332 media_image2.png Greyscale Specification – C4F9CH2CH(OH) CHMA Since Vanderlaan and Ito both disclose polymer compositions comprising silicone-based components for ophthalmic contact lenses, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have added Ito’s fluoroalkyl acrylate having a perfluoroalkyl group of 4 carbon atoms into Vanderlaan’s composition to yield a polymer that exhibits flexibility, wettability, sufficient oxygen permeability, and lipid-stain resistance as taught by Ito (Ito, [0068]-[0069]). Regarding Claim 2, modified Vanderlaan teaches the fluorine-containing monomer having a perfluoroalkyl group R’1 of 4 carbon atoms has six or more carbon atoms excluding the carbon atoms in the polymerizable functional group (Ito, [0068]-[0069]). PNG media_image1.png 80 248 media_image1.png Greyscale Ito – Fluoroalkyl acrylate Regarding Claim 3, modified Vanderlaan teaches the polymer composition (material) can include a compatibilizing agent with at least one polymerizable group (i.e., a compatibilizing monomer (a-2)) that can be included in an amount of about 0 to about 5 wt% of the polymer composition (Vanderlaan, [0013], Claim 9). Vanderlaan’s compatibilizing monomer (a-2) content overlaps the claimed range of 5-50 mass%, and therefore, establishes a prima facie case of obviousness over the claimed range (MPEP 2144.05, I). Regarding Claim 5, modified Vanderlaan teaches the high molecular weight hydrophilic polymer (a hydrophilic polymer component (b)) is included in a preferred amount of about 3-15 wt% based upon the total of all reactive components (Vanderlaan, [0068]-[0070]). Modified Vanderlaan’s range is completely encompassed within the claimed range of 1-30 mass%, and therefore, satisfies the claimed range (MPEP 2131.03). Regarding Claim 6, modified Vanderlaan teaches the fluoroalkyl acrylate having a perfluoroalkyl group of 4-6 carbon atoms (a-2) has an acrylate polymerizable functional group, an intermediate portion containing a hydroxyl group, and the perfluoroalkyl group of 4-6 carbon atoms as a hydrophobic terminal group (Ito, [0068]-[0069]). Regarding Claim 7, modified Vanderlaan teaches the fluoroalkyl acrylate having a perfluoroalkyl group of 4-6 carbon atoms (a-2) can have a branched hydrocarbon group such as 3-(perfluoro-3-methylbutyl)-2-hydroxypropyl (meth)acrylate (Ito, [0065]-[0069]). Regarding Claim 8, modified Vanderlaan teaches the fluoroalkyl acrylate having a perfluoroalkyl group (a-2) has a Z (meth)acryloyl group, an A divalent atomic group containing a hydroxyl group (a hydrogen bonding proton-containing group), and a B hydrocarbon group having 3-15 carbon atoms, where a total number of carbon atoms in A+B is 4 or more (Ito, [0065]-[0069]). PNG media_image1.png 80 248 media_image1.png Greyscale Ito – Fluoroalkyl acrylate Regarding Claims 9 and 10, modified Vanderlaan teaches the fluoroalkyl acrylate having a perfluoroalkyl group (a-2) has the A divalent group satisfying formula (i) of claim 9, where X is -O-; Ra1 can be an alkylene group of 3 carbon atoms and a hydroxyl group (-CH2-CH(OH)-CH2-); and r1, r2, r3, and r4 are 0 (Ito, [0065]-[0069]). Regarding Claim 11, modified Vanderlaan teaches the polymer composition (material) can include a copolymerizable dye (i.e., a polymerizable dyestuff) (Vanderlaan, [0077]). Regarding Claim 12, modified Vanderlaan teaches the fluoroalkyl acrylate having a perfluoroalkyl group (a-2) has a hydroxyl group (a hydrogen bonding proton-containing group) (Ito, [0065]-[0069]). Regarding Claim 13, modified Vanderlaan teaches the silicone containing component (a-1) is a monomer that contains a siloxane bond, is free of hydroxyl groups, and contains a nitrogen atom (Vanderlaan, [0060], Formulae IX & X). PNG media_image3.png 173 697 media_image3.png Greyscale Vanderlaan – Formula IX PNG media_image4.png 270 708 media_image4.png Greyscale Vanderlaan – Formula X Regarding Claim 14, modified Vanderlaan teaches the high molecular weight hydrophilic polymer (hydrophilic polymer component (b)) has a weight average molecular weight of no less than 100,000 (Vanderlaan, [0068]). Modified Vanderlaan’s range is identical to the claimed range, and therefore, satisfies the claimed range (MPEP 2131.03). Regarding Claims 15 and 16, modified Vanderlaan teaches the high molecular weight hydrophilic polymer (hydrophilic polymer component (b)) can be a polyvinyl amide such as preferably poly-N-vinyl pyrrolidone (Vanderlaan, [0068]-[0071]). Regarding Claims 18 and 19, modified Vanderlaan teaches ophthalmic medical contact lenses comprising the polymer composition as discussed above for claim 1 (Vanderlaan, [0002], [0009], [0014]-[0015], [0083]). Claim 17 is rejected under 35 U.S.C. 103 as being unpatentable over Vanderlaan et al. (US 2010/0280146 A1) in view of Ito et al. (US 2004/0054106 A1) as applied to claim 1 above, and further in view of Satake et al. (US 2016/0289368 A1). Regarding Claim 17, modified Vanderlaan teaches the polymer composition (material) for ophthalmic contact lenses as discussed above for claim 1. Modified Vanderlaan teaches the polymer composition can exhibit modulus ranging from 64±4 psi to 118.4±7.3 psi (60 psi to 125.7 psi; 0.41 MPa to 0.87 MPa) (Vanderlaan, [0096], [0142]-[0146], Tables 5 & 8). Modified Vanderlaan remains silent regarding a Young’s modulus of from 0.05 MPa to 2.0 MPa. Satake, however, teaches a polymer for an ophthalmic contact lens having a Young’s modulus of from 0.3 MPa to 1.0 MPa to achieve excellent wearing comfort, sufficiently high flexibility, and adequate degree of deformation recovery property (Satake, [0010]-[0012], [0025]-[0026]). Satake’s Young’s modulus range is completely encompassed within the claimed range of 0.05-2.0 MPa, and therefore, satisfies the claimed range (MPEP 2131.03). Satake teaches the polymer comprises a polysiloxane-based monomer and a hydrophilic monomer (Satake, [0015]-[0017], [0038]-[0054]). Since modified Vanderlaan and Satake both disclose polymer compositions comprising silicone-based components for ophthalmic contact lenses exhibiting similar modulus properties, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have adjusted and optimized Vanderlaan’s composition Young’s modulus between 0.3 MPa to 1.0 MPa to yield a polymer that achieves excellent wearing comfort, sufficiently high flexibility, and adequate degree of deformation recovery property as taught by Satake (Satake, [0010]-[0012], [0025]-[0026], MPEP 2144.05, II). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ELI D STRAH whose telephone number is (571)270-7088. The examiner can normally be reached M-F 9 am - 7 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Aaron Austin can be reached on 571-272-8935. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eli D. Strah/Primary Examiner, Art Unit 1782
Read full office action

Prosecution Timeline

Dec 17, 2024
Application Filed
Dec 13, 2025
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12604448
DISPLAY MODULE, MANUFACTURING METHOD THEREOF, AND MOBILE TERMINAL
2y 5m to grant Granted Apr 14, 2026
Patent 12600806
VINYL CHLORIDE RESIN COMPOSITION, VINYL CHLORIDE RESIN MOLDED PRODUCT, AND LAMINATE
2y 5m to grant Granted Apr 14, 2026
Patent 12597678
Unit Cell and Battery Cell Comprising the Same
2y 5m to grant Granted Apr 07, 2026
Patent 12583956
OLEFIN-BASED POLYMER, FILM PREPARED THEREFROM, AND PREPARATION METHODS THEREFOR
2y 5m to grant Granted Mar 24, 2026
Patent 12576628
METHOD FOR MANUFACTURING IMAGE DISPLAY DEVICE, PHOTOCURABLE RESIN COMPOSITION, AND LIGHT TRANSMITTING CURED RESIN LAYER
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
94%
With Interview (+43.9%)
3y 7m
Median Time to Grant
Low
PTA Risk
Based on 479 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month